Rehabilitation Training After Stroke

NCT02429180 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2019-03-19

No results posted yet for this study

Summary

A pilot study that will evaluate the feasibility and acceptability of procedures to inform the design and delivery of a definitive RCT of ReTrain (which would assess the clinical and cost effectiveness of ReTrain for stroke survivors).

Conditions

Interventions

OTHER

Rehabilitation

ReTrain: an exercise-based functional training programme comprising two phases: (1) weekly supervised sessions; (2) monthly drop-in sessions, plus home-based exercise in each phase. * Week 1: one-to-one consultations with trainer to introduce programme, assess individual's concerns and capabilities, introduce and negotiate initial goals * Weeks 2-11: bi-weekly 90 minute group class with group-based activities and one-to-one coaching, based on ongoing goal negotiation review and progression. * Week 12: one-to-one consultations with trainer to review goals and plan ongoing unsupervised exercise programme * Weeks 13-24: monthly drop-in sessions for one-to-one consultation, support and progression.

Sponsors & Collaborators

  • The Stroke Association, United Kingdom

    collaborator OTHER
  • University of Exeter

    lead OTHER

Principal Investigators

  • Sarah Dean, PhD · University of Exeter Medical School

  • Rod Taylor, Prof · University of Exeter Medical School

  • Anne Forster, Prof · University of Leeds

  • Anne Spencer, Prof · University of Exeter Medical School

  • Martin James, Dr · Royal Devon and Exeter NHS Foundation Trust

  • Rhoda Allison, Dr · Torbay & Southern Devon Health & Care Trust

  • Shirley Stevens, Mrs · PenPIG

  • Meriel Norris, Dr · Brunel University

  • Leon Poltawski, Dr · University of Exeter Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-01-27
Completion
2016-01-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429180 on ClinicalTrials.gov